# DESCRIPTION

## FIELD OF THE INVENTION

- relate to IspD enzyme inhibitors

## BACKGROUND OF THE INVENTION

- motivate need for new antimalarial agents

## SUMMARY OF THE INVENTION

- introduce IspD enzyme inhibitor compounds
- describe methods of treating malaria
- outline pharmaceutical compositions

## DESCRIPTION OF THE PREFERRED EMBODIMENTS

- introduce MEP pathway
- describe isoprenoid biosynthesis via MEP pathway
- motivate IspD enzyme as therapeutic target
- describe compounds of Formula I
- describe various embodiments of compounds of Formula I
- describe compounds of Formula II
- describe various embodiments of compounds of Formula II
- describe additional IspD inhibitors
- describe methods of treating diseases caused by organisms possessing MEP pathway
- describe pharmaceutical compositions containing IspD inhibitors
- describe formulation of pharmaceutical compositions
- describe routes of administration

### EXAMPLES

- describe inhibition of malaria IspD enzyme
- describe metabolic profiling of inhibitor-treated malaria parasites

